Bishokarma S, Shrestha S, Ranabhat K, Koirala S, Shrestha D, Panth R, Gongal D N
Department of Neurosurgery, Upendra Devkota Memorial National Institute of Neurological and Allied Sciences, Bansbari, Kathmandu, Nepal.
Department of Radiology, Upendra Devkota Memorial National Institute of Neurological and Allied Sciences, Bansbari, Kathmandu, Nepal.
Kathmandu Univ Med J (KUMJ). 2018;16(64):328-332.
Background Craniopharyngiomas (CPs) are rare epithelial tumors arising from the Rathke's pouch remnant located along the path of the craniopharyngeal duct accounting for 1.2-4% of all primary intracranial brain tumors, the primary treatment of which is surgery. Objective Whether radical surgical resection or partial resection followed by radiotherapy is a topic of debate. We presented our 12 years single center experience on surgical resection of craniopharyngioma. Method This was a descriptive cross-sectional study conducted among forty-five patients who underwent transcranial resection of craniopharyngioma during a period of 12 years. Data were collected from medical record archives. Glassgow outcome score (GOS), electrolyte imbalance and visual complications were assessed as outcome measure. GOS > 3 was considered favorable while score ≤ 3 was considered unfavorable. Recurrence of tumors were analyzed. Result Out of 45 patients, 28 patients were male with male to female ration of 1.64. Mean age was 32.22±16.42 years. Supra-sellar craniopharyngioma were the most common location. Gross total resection was accomplished in 32 patients (71.1%) while subtotal resection among 13 patients (28.9%). Post-operative Diabetes Insipidus was developed among 35 patients (77.7%). Adamantinomatous craniopharyngioma was the most common histopathological type. Postoperative MRI with contrast was repeated to ascertain the completeness of resection. All patient with subtotal resection received radiotherapy. Follow up period ranged from 3 months to 8 years with mean of 4.2 years. Favorable outcome (GOS>3) was seen among 41 patients while unfavorable among 4 patients. Recurrence seen among 4 patients (8.9%). Overall mortality was 4 (8.8%). Conclusion Gross total excision of craniopharyngioma has a favorable outcome with acceptable morbidity.
颅咽管瘤(CPs)是一种罕见的上皮性肿瘤,起源于沿颅咽管路径的拉克囊残余组织,占所有原发性颅内脑肿瘤的1.2 - 4%,其主要治疗方法是手术。目的:根治性手术切除还是部分切除后放疗一直是一个有争议的话题。我们展示了我们12年单中心颅咽管瘤手术切除的经验。方法:这是一项描述性横断面研究,对45例在12年期间接受经颅颅咽管瘤切除术的患者进行。数据从病历档案中收集。将格拉斯哥预后评分(GOS)、电解质失衡和视觉并发症作为预后指标进行评估。GOS>3被认为预后良好,而评分≤3被认为预后不良。分析肿瘤的复发情况。结果:45例患者中,28例为男性,男女比例为1.64。平均年龄为32.22±16.42岁。鞍上颅咽管瘤是最常见的部位。32例患者(71.1%)实现了全切除,13例患者(28.9%)为次全切除。35例患者(77.7%)术后发生尿崩症。成釉细胞瘤型颅咽管瘤是最常见的组织病理学类型。术后重复进行增强MRI以确定切除的完整性。所有次全切除的患者均接受了放疗。随访期为3个月至8年,平均4.2年。41例患者预后良好(GOS>3),4例患者预后不良。4例患者(8.9%)出现复发。总死亡率为4例(8.8%)。结论:颅咽管瘤的全切除预后良好,发病率可接受。